"Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses." Nathan and Rossin et al

Supplemental Tables S3 and S4 for article titled "Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses."

TABLE S3. List of SARS-CoV-2 epitopes tested by HLA class I-peptide stability assay. Each row indicates a highly networked SARS-CoV-2 epitope and columns include the following: HLA, Peptide #, Epitope Code, Epitope Sequence, Gene, Amino Acid, Protein, Protein Region, Network Score, NetMHC Binding Score, HLA Stabilization, 50% Experimental Binder (YES/NO).

TABLE S4. Sequences of Highly Networked HLA stabilizing SARS-CoV-2 Epitopes in the B.1.117, B.1.351, P.1 and B.1.617 Variants, Related to Figure 3. Mutations from ancestral strain delineated in bold. Each row indicates a highly networked SARS-CoV-2 epitope and columns include the following: Epitope Code, WT Epitope Sequence, B.1.1.7 (UK Variant), B.1.351 (South African Variant), P.1 (Brazilian Variant), B.1.617 (Indian Variant), Protein, Protein Region, Amino Acid, Network Score.

Please contact Anusha Nathan at [e-mail] with questions.